コンテンツへスキップ
Merck
  • Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication.

Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication.

Toxicology and applied pharmacology (2014-12-03)
Stephen T Vito, Adam T Austin, Christopher N Banks, Bora Inceoglu, Donald A Bruun, Dorota Zolkowska, Daniel J Tancredi, Michael A Rogawski, Bruce D Hammock, Pamela J Lein
要旨

Tetramethylenedisulfotetramine (TETS) is a potent convulsant poison for which there is currently no approved antidote. The convulsant action of TETS is thought to be mediated by inhibition of type A gamma-aminobutyric acid receptor (GABAAR) function. We, therefore, investigated the effects of post-exposure administration of diazepam, a GABAAR positive allosteric modulator, on seizure activity, death and neuroinflammation in adult male Swiss mice injected with a lethal dose of TETS (0.15mg/kg, ip). Administration of a high dose of diazepam (5mg/kg, ip) immediately following the second clonic seizure (approximately 20min post-TETS injection) effectively prevented progression to tonic seizures and death. However, this treatment did not prevent persistent reactive astrogliosis and microglial activation, as determined by GFAP and Iba-1 immunoreactivity and microglial cell morphology. Inhibition of soluble epoxide hydrolase (sEH) has been shown to exert potent anti-inflammatory effects and to increase survival in mice intoxicated with other GABAAR antagonists. The sEH inhibitor TUPS (1mg/kg, ip) administered immediately after the second clonic seizure did not protect TETS-intoxicated animals from tonic seizures or death. Combined administration of diazepam (5mg/kg, ip) and TUPS (1mg/kg, ip, starting 1h after diazepam and repeated every 24h) prevented TETS-induced lethality and influenced signs of neuroinflammation in some brain regions. Significantly decreased microglial activation and enhanced reactive astrogliosis were observed in the hippocampus, with no changes in the cortex. Combining an agent that targets specific anti-inflammatory mechanisms with a traditional antiseizure drug may enhance treatment outcome in TETS intoxication.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
アセトン, ACS reagent, ≥99.5%
Sigma-Aldrich
塩酸, ACS reagent, 37%
Sigma-Aldrich
アセトン, suitable for HPLC, ≥99.9%
Sigma-Aldrich
塩酸, ACS reagent, 37%
Sigma-Aldrich
アセトン, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%
Sigma-Aldrich
塩化水素 溶液, 4.0 M in dioxane
Sigma-Aldrich
ヘキサン, suitable for HPLC, ≥97.0% (GC)
Sigma-Aldrich
ヘキサン, suitable for HPLC, ≥95%
Sigma-Aldrich
アセトン, Laboratory Reagent, ≥99.5%
Sigma-Aldrich
ヘキサン, ReagentPlus®, ≥99%
Sigma-Aldrich
ベンジルアルコール, ReagentPlus®, ≥99%
Sigma-Aldrich
塩酸 溶液, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
塩酸, meets analytical specification of Ph. Eur., BP, NF, fuming, 36.5-38%
Sigma-Aldrich
ヘキサン, Laboratory Reagent, ≥95%
Sigma-Aldrich
ヘキサン, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99% (GC)
Sigma-Aldrich
塩酸, 37 wt. % in H2O, 99.999% trace metals basis
Sigma-Aldrich
ヘキサン, HPLC Plus, for HPLC, GC, and residue analysis, ≥95%
Sigma-Aldrich
アセトン, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
Sigma-Aldrich
塩酸, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
塩化水素 溶液, 2.0 M in diethyl ether
Sigma-Aldrich
塩酸, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., fuming, ≥37%, APHA: ≤10
Sigma-Aldrich
ベンジルアルコール, ACS reagent, ≥99.0%
Sigma-Aldrich
プロピレングリコール, ≥99.5% (GC), FCC, FG
Supelco
塩酸 溶液, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
アセトン, suitable for HPLC, ≥99.8%
Sigma-Aldrich
アセトン, ACS reagent, ≥99.5%
Sigma-Aldrich
塩酸, SAJ first grade, 35.0-37.0%
USP
ベンジルアルコール, United States Pharmacopeia (USP) Reference Standard
USP
アセトン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
塩化水素 溶液, 1.0 M in diethyl ether